AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia.
BEERSE, Belgium, April 27 /PRNewswire/ -- Janssen-Cilag International NV announced today that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA(R) (paliperidone prolonged release tablets). INVEGA(R) is a new, once-daily, prolonged release oral medication, for the treatment of schizophrenia.
The CHMP is the committee responsible for the scientific assessment of products seeking one centralised marketing authorisation applicable throughout the European Union. Janssen-Cilag anticipates receiving the Marketing Authorisation from the European Commission by mid-year 2007.
The recommended indication is: "Paliperidone prolonged release tablets is indicated for the treatment of…
- United Research Laboratories/Mutual Pharmaceutical Company Announce ANDA Filing...
- Press release article from: PR Newswire August 18, 2006 700+ words
...Mutual's guaifenesin extended-release tablets, 600 mg and 1200 mg. Guaifenesin extended-release tablets are currently marketed over-the...that its guaifenesin extended-release tablets are bioequivalent to Mucinex(R...
- Barr Receives Tentative Approval for Generic Niaspan(R) 500 mg and 750 mg...
- Press release article from: PR Newswire June 16, 2003 700+ words
...R) 500 mg and 750 mg Extended-Release Tablets (Niacin Extended-Release Tablet...Niaspan 500 mg and 750 mg Extended-Release Tablets and a trial in the Federal District...Niaspan(R) 1000 mg Extended-Release Tablets (Niacin Extended-Release Tablet...
- Taro Receives Final FDA Approval for Carbamazepine Extended-Release Tablets.
- Press release article from: Business Wire April 3, 2009 700+ words
...Application ("ANDA") for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg ("carbamazepine extended-release tablets"). Taro's carbamazepine extended-release tablets are bioequivalent to the reference listed drug...
- Barr Receives Tentative Approval for Generic Niaspan(R) 1000 mg...
- Press release article from: PR Newswire May 12, 2003 700+ words
...Niaspan(R) 1000 mg Extended-Release Tablets (Niacin Extended-Release Tablet...Kos for Niaspan 1000 mg Extended-Release Tablets and a trial in the Federal District...Application (ANDA) for Niacin Extended-Release Tablets had been accepted for filing in November...
- Ranbaxy Receives FDA Approval to Market Loratadine and Pseudoephedrine Sulfate...
- Press release article from: PR Newswire September 24, 2004 700+ words
...and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg (24-Hour Formulation...and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg (24-Hour Formulation...Claritin-D(R) 24-Hour Extended Release Tablets of Schering Corporation. Total sales...
- Barr receives tentative approval for generic Niaspan 500 mg and 750 mg...
- News wire article from: Asia Africa Intelligence Wire June 16, 2003 700+ words
...Niaspan 500 mg and 750 mg Extended-Release Tablets (niacin extended-release tablet...Niaspan 500 mg and 750 mg Extended-Release Tablets and a trial in the Federal District...of Kos' Niaspan 1000 mg Extended-Release Tablets (niacin extended-release tablet...
- Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of...
- Press release article from: Business Wire September 2, 2008 700+ words
...oxycodone hydrochloride extended-release tablets for a limited period of time ending...oxycodone hydrochloride extended-release tablets before the end of September 2008...oxycodone hydrochloride extended-release Tablets in 10mg, 20mg, 40mg and 80mg dosage...
- IMPAX Comments On Schering Lawsuit Related to Generic Version of Claritin-D...
- Press release article from: Business Wire February 12, 2001 700+ words
...pseudoephedrine sulfate) Extended Release Tablets. Schering markets Claritin-D 12-Hour Extended Release Tablets for the relief of symptoms of seasonal...Claritin-D 12-Hour Extended Release Tablets. IMPAX made that application under...
- Taro receives final FDA approval for Carbamazepine Extended-Release Tablets...
- News wire article from: Chemical Business Newsbase April 3, 2009 700+ words
...Application (ANDA) for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg (carbamazepine extended-release tablets). Taros carbamazepine extended-release tablets are bioequivalent to the reference listed drug Tegretol...
- Barr Receives Tentative Approval for Metformin Hydrochloride Extended-Release...
- Press release article from: PR Newswire October 31, 2003 700+ words
...Metformin Hydrochloride extended- release tablets) 500 mg Tablet. The Company anticipates...Metformin Hydrochloride extended-release tablets, as a monotherapy, are indicated...Metformin Hydrochloride extended-release tablets will compete in a market that had...
Source: HighBeam Research, INVEGA(R) Receives Positive Opinion From European Committee for Human...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
